Table 2. Characteristics about women who have menopausal hormone.
| MHT chracteristics | Tibolone | Combined Estrogen plus progestin by manufacturer | Oral Estrogen | Combined Estrogen plus progestin by physician | Topical estrogen | Total MHT |
|---|---|---|---|---|---|---|
| Median duration (months) | 25 [11–58] | 25 [11–58] | 15 [9–40] | 16 [9–35] | 13 [8–24] | 23 [10–55] |
| Duration (years) | ||||||
| <5 | 145,461 (75.5) | 97,060 (75.7) | 43,376 (82.8) | 5,597 (87.1) | 1,943 (95.2) | 293,437 (76.9) |
| 5–9.9 | 34,634 (18) | 23,786 (18.6) | 6,280 (12) | 641 (10) | 93 (4.6) | 65,434 (17.1) |
| ≥10 | 12,576 (6.5) | 7,322 (5.7) | 2,748 (5.2) | 189 (2.9) | 5 (0.2) | 22,840 (6) |
| Duration of previous other MHT (years) | ||||||
| <5 | 187,369 (97.2) | 126,104 (98.4) | 51,635 (98.5) | 5,352 (83.3) | 2,016 (98.8) | 372,476 (97.6) |
| 5–9.9 | 4,737 (2.5) | 1,895 (1.5) | 691 (1.3) | 799 (12.4) | 24 (1.2) | 8,146 (2.1) |
| ≥10 | 565 (0.3) | 169 (0.1) | 78 (0.1) | 276 (4.3) | 1 (0) | 1,089 (0.3) |
| Last dosage of Tibolone (per day) | ||||||
| 1.25mg | 1,819 (0.9) | |||||
| 2.5mg | 190,658 (99) | |||||
| over 5mg | 175 (0.1) | |||||
| Prescribed specialty | ||||||
| Gynecology | 64,852 (33.7) | 58,694 (45.8) | 21,624 (41.3) | 1,532 (23.8) | 510 (25) | 147,212 (38.6) |
| Non-gynecology | 127,819 (66.3) | 69,474 (54.2) | 30,780 (58.7) | 4,895 (76.2) | 1,531 (75) | 234,499 (61.4) |
MHT, menopausal hormone therapy
Data are expressed as the number (%) or median [25th percentile, 75th percentile].